Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · IEX Real-Time Price · USD
22.70
+0.02 (0.09%)
Apr 24, 2024, 3:59 PM EDT - Market closed
Bicycle Therapeutics Market Cap
Bicycle Therapeutics has a market cap or net worth of $961.93 million as of April 24, 2024. Its market cap has increased by 57.85% in one year.
Market Cap
961.93M
Enterprise Value
468.37M
1-Year Change
57.85%
Ranking
Category
Stock Price
$22.70
Market Cap Chart
Since May 23, 2019, Bicycle Therapeutics's market cap has increased from $212.40M to $961.93M, an increase of 352.89%. That is a compound annual growth rate of 35.91%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 965.90M | 0.49% |
Apr 22, 2024 | 961.20M | -3.75% |
Apr 19, 2024 | 998.60M | -4.25% |
Apr 18, 2024 | 1.04B | 12.24% |
Apr 17, 2024 | 929.20M | -0.50% |
Apr 16, 2024 | 933.90M | 0.51% |
Apr 15, 2024 | 929.20M | -2.16% |
Apr 12, 2024 | 949.70M | -0.89% |
Apr 11, 2024 | 958.20M | -2.13% |
Apr 10, 2024 | 979.10M | -0.35% |
Apr 9, 2024 | 982.50M | 0.48% |
Apr 8, 2024 | 977.80M | 1.01% |
Apr 5, 2024 | 968.00M | 0.53% |
Apr 4, 2024 | 962.90M | -3.04% |
Apr 3, 2024 | 993.10M | -1.73% |
Apr 2, 2024 | 1.01B | -2.14% |
Apr 1, 2024 | 1.03B | -2.61% |
Mar 28, 2024 | 1.06B | 1.43% |
Mar 27, 2024 | 1.05B | 0.09% |
Mar 26, 2024 | 1.04B | -3.55% |
Mar 25, 2024 | 1.08B | -0.23% |
Mar 22, 2024 | 1.09B | -1.40% |
Mar 21, 2024 | 1.10B | 0.94% |
Mar 20, 2024 | 1.09B | 4.31% |
Mar 19, 2024 | 1.05B | 1.78% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Arcutis Biotherapeutics | 1.03B |
Liquidia | 1.02B |
Standard BioTools | 995.93M |
Abivax | 991.58M |
Maravai LifeSciences Holdings | 990.31M |
Alignment Healthcare | 968.54M |
MacroGenics | 961.46M |
Innoviva | 942.40M |